TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9060793

Group type: COMPARATOR
Intervention: Enalapril (5 mg once per day) plus placebo; n = 14
Number of subjects: 46

Group type: COMPARATOR
Intervention: Nisoldipine (10 mg two times per day) plus placebo; n = 18
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Enalapril (5 mg once per day) plus Nisoldipine (10 mg two times per day); n = 14
Number of subjects: 46
Study: 8342506

Group type: EXPERIMENTAL
Intervention: Type IA antiarrhythmic therapy
Number of subjects: 15
Study: 3485054

Group type: EXPERIMENTAL
Intervention: PAMBA (1.0 g)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Lactose (placebo)
Number of subjects: 74
Study: 29678799

Group type: EXPERIMENTAL
Intervention: WebQuit - 5-week users
Number of subjects: 2637

Group type: EXPERIMENTAL
Intervention: WebQuit - 52-week users
Number of subjects: 2637

Group type: EXPERIMENTAL
Intervention: Smokefree - 5-week users
Number of subjects: 2637

Group type: COMPARATOR
Intervention: Smokefree - 4-week users
Number of subjects: 2637
Study: 27135464

Group type: EXPERIMENTAL
Intervention: Memory and Attention Adaptation Training (MAAT)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Supportive therapy (control)
Number of subjects: 47
Study: 24534013

Group type: EXPERIMENTAL
Intervention: Typhoid vaccination
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline control injection
Number of subjects: 20
Study: 23402088

Group type: EXPERIMENTAL
Intervention: Topical Diltiazem gel (2%)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Topical Glyceril trinitrate ointment (0.2%)
Number of subjects: 61
Study: 20303606

Group type: EXPERIMENTAL
Intervention: Low energy biphasic external cardioversion at 20 or 30 J
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low energy biphasic external cardioversion
Number of subjects: 0
Study: 18697207

Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2a at 270 microg/week plus ribavirin at 1600 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2a at 270 microg/week plus ribavirin at 1200 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: peginterferon alfa‐2a at 180 microg/week plus ribavirin at 1600 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: peginterferon alfa‐2a at 180 microg/week plus ribavirin at 1200 mg/day
Number of subjects: 0
Study: 15558604

Group type: EXPERIMENTAL
Intervention: bLES
Number of subjects: 60

Group type: COMPARATOR
Intervention: Survanta
Number of subjects: 60
Study: 12608685

Group type: EXPERIMENTAL
Intervention: STARS for Families program (intervention)
Number of subjects: 650
Study: 10547245

Group type: EXPERIMENTAL
Intervention: 15 microg OspA vaccine
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: 30 microg OspA vaccine
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Both doses of OspA vaccine
Number of subjects: 250
Study: 9081395

Group type: EXPERIMENTAL
Intervention: Oral dexamethasone 4 mg twice daily as maintenance
Number of subjects: 94

Group type: COMPARATOR
Intervention: No maintenance
Number of subjects: 94
Study: 1807972

Group type: EXPERIMENTAL
Intervention: Amoxapine
Number of subjects: 3

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 6338992

Group type: EXPERIMENTAL
Intervention: Graduated compression stockings
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (no stockings)
Number of subjects: 200
Study: 30908263

Group type: EXPERIMENTAL
Intervention: Noncontact ultrasound tactile display
Number of subjects: 0
Study: 30293053

Group type: EXPERIMENTAL
Intervention: Problem Based Learning (PBL)
Number of subjects: 108

Group type: COMPARATOR
Intervention: PBL + Active Learning Model for Critical Thinking (ALMCT)
Number of subjects: 108
Study: 26912506

Group type: EXPERIMENTAL
Intervention: Remifentanil (i.v. infusion 1-5 µg/kg/h)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Dexmedetomidine (loading dose 0.3-0.4 µg/kg followed by i.v. infusion 0.2-1 µg/kg/h)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 75
Study: 24390828

Group type: EXPERIMENTAL
Intervention: L2 paravertebral block (PVB)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Lumbar plexus block (LPB)
Number of subjects: 53
Study: 22465256

Group type: EXPERIMENTAL
Intervention: Weekly, group-based weight management intervention with individualized calorie intake goal, second counseling session, and weekly group meetings until birth.
Number of subjects: 160

Group type: COMPARATOR
Intervention: Single dietary advice control condition.
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Weekly, group-based weight management intervention.
Number of subjects: 160
Study: 20667691

Group type: EXPERIMENTAL
Intervention: Home-based training program for 6 months (Group 1)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No home-based training (Group 2)
Number of subjects: 11
Study: 17355792

Group type: EXPERIMENTAL
Intervention: Dental stent during radiotherapy
Number of subjects: 43
Study: 15616247

Group type: EXPERIMENTAL
Intervention: Screening approach using fasting capillary glucose combined with age and BMI
Number of subjects: 30383

Group type: EXPERIMENTAL
Intervention: Screening approach using fasting capillary glucose
Number of subjects: 30383

Group type: EXPERIMENTAL
Intervention: Age and BMI as risk factors
Number of subjects: 30383

Group type: EXPERIMENTAL
Intervention: Fasting capillary glucose
Number of subjects: 30383
Study: 12780478

Group type: EXPERIMENTAL
Intervention: General Health Questionnaire-12 (GHQ-12)
Number of subjects: 336
Study: 10559513

Group type: EXPERIMENTAL
Intervention: Isoflavones (86 mg daily for two menstrual cycles)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (for two menstrual cycles)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Isoflavones and Placebo (cross-over effect)
Number of subjects: 14
Study: 8698011

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Halofantrine
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Fansidar
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Overall treatment comparison
Number of subjects: 188
Study: 1757607

Group type: EXPERIMENTAL
Intervention: 0.05% halobetasol propionate ointment
Number of subjects: 84

Group type: COMPARATOR
Intervention: 0.1% betamethasone valerate ointment
Number of subjects: 84
Study: 7129299

Group type: EXPERIMENTAL
Intervention: 5 mg/kg thiopental
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 1 mg/kg methohexital
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study: 31879076

Group type: EXPERIMENTAL
Intervention: Outpatient Nursing Nutritional Intervention (ONNI)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 152
Study: 30640585

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Lower back (LB) group
Number of subjects: 42
Study: 28705573

Group type: EXPERIMENTAL
Intervention: Axitinib (oral administration for up to 12 weeks)
Number of subjects: 24
Study: 26010861

Group type: EXPERIMENTAL
Intervention: Estradiol
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 23314316

Group type: COMPARATOR
Intervention: Placebo (n = 101)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: α‐tocopherol (n = 102)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: γ‐tocopherol (n = 102)
Number of subjects: 305
Study: 20869883

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 50
Study: 19017314

Group type: EXPERIMENTAL
Intervention: Mitoxantrone (mean cumulative dose 35.4+/‐21.6 mg/m(2))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 20
Study: 16500469

Group type: EXPERIMENTAL
Intervention: FloSeal (FS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (saline-soaked neuropatties)
Number of subjects: 45
Study: 14716340

Group type: EXPERIMENTAL
Intervention: Immunotherapy (group B, n=7)
Number of subjects: 13

Group type: COMPARATOR
Intervention: No therapy (group A, n=6)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Immunotherapy in patients relapsing directly into CRel (n=4)
Number of subjects: 13
Study: 11129360

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Support group
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 184
Study: 9293831

Group type: EXPERIMENTAL
Intervention: Transfusions to maintain hemoglobin level of 10 g/dL
Number of subjects: 99

Group type: COMPARATOR
Intervention: Transfusions to maintain hemoglobin level of 9 g/dL
Number of subjects: 99
Study: 8112806

Group type: EXPERIMENTAL
Intervention: Carbohydrate and fat-rich diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protein coadministration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fasting subjects
Number of subjects: 0
Study: 3528460

Group type: EXPERIMENTAL
Intervention: Micromechanical retainers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Macromechanical retainers
Number of subjects: 0
Study: 31495655

Group type: EXPERIMENTAL
Intervention: RehaCom cognitive rehabilitation software (ten 45‐min sessions in five weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 50
Study: 30646107

Group type: EXPERIMENTAL
Intervention: Greening intervention
Number of subjects: 0
Study: 27673378

Group type: EXPERIMENTAL
Intervention: Minimal incision, multifidus-sparing MED
Number of subjects: 73

Group type: COMPARATOR
Intervention: Conventional microdiskectomy
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 73
Study: 24321374

Group type: EXPERIMENTAL
Intervention: Drisapersen 3mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drisapersen 6mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drisapersen 9mg/kg
Number of subjects: 0
Study: 22860301

Group type: EXPERIMENTAL
Intervention: Dorsal branch of the radial artery (DRA)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Radial artery (RA)
Number of subjects: 76
Study: 20456815

Group type: EXPERIMENTAL
Intervention: Raw unsalted peanuts (56 g daily for 4 weeks)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Roasted unsalted peanuts (56 g daily for 4 weeks)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Roasted salted peanuts (56 g daily for 4 weeks)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Honey roasted peanuts (56 g daily for 4 weeks)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Peanut butter (56 g daily for 4 weeks)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Individuals with elevated fasting plasma lipids
Number of subjects: 118
Study: 19138915

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (1.5 mg.kg(‐1) bolus followed by 2 mg.kg(‐1).hr(‐1) continuous infusion)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (fentanyl 3 microg.kg(‐1))
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study: 17238334

Group type: EXPERIMENTAL
Intervention: Decision support system for implementing clinical guidelines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Care with system support of the guideline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care without system support of the guideline
Number of subjects: 0
Study: 14698710

Group type: EXPERIMENTAL
Intervention: Magnet-activated stimulation during VNS therapy
Number of subjects: 0
Study: 11303323

Group type: EXPERIMENTAL
Intervention: Hyperthyroidism (overt: SDI 0.121; latent: SDI 0.158)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Hypothyroidism (overt: SDI 0.617; latent: SDI 0.471)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Controls (healthy individuals: SDI 0.345)
Number of subjects: 171
Study: 8791276

Group type: EXPERIMENTAL
Intervention: Interferon-alpha and high dose interleukin-2
Number of subjects: 65
Study: 1365669

Group type: EXPERIMENTAL
Intervention: 6 mg co-dergocrine mesylate (CDM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 9 mg co-dergocrine mesylate (CDM)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2857949

Group type: EXPERIMENTAL
Intervention: Paracentesis plus intravenous albumin infusion
Number of subjects: 72

Group type: COMPARATOR
Intervention: Diuretics
Number of subjects: 72
Study: 29198729

Group type: EXPERIMENTAL
Intervention: My Guide (psychoeducation & self-management program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: My Health (health education control condition)
Number of subjects: 0
Study: 26577499

Group type: EXPERIMENTAL
Intervention: Invagination
Number of subjects: 132

Group type: COMPARATOR
Intervention: Duct-to-mucosa anastomosis
Number of subjects: 132
Study: 24945513

Group type: EXPERIMENTAL
Intervention: Haas appliance
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hyrax appliance
Number of subjects: 48
Study: 23518431

Group type: EXPERIMENTAL
Intervention: Intraarticular bovine thrombin at the time of wound closure
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no bovine thrombin)
Number of subjects: 80
Study: 21425701

Group type: COMPARATOR
Intervention: Individuals acting alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dyads performing a similar task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observers perceiving dyads
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observers perceiving individuals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observers' perception of critical action boundaries
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observers perceiving critical action boundaries for dyads
Number of subjects: 0
Study: 18439602

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided embryo transfer (US ET)
Number of subjects: 373

Group type: COMPARATOR
Intervention: Clinical touch embryo transfer (Clinical touch ET)
Number of subjects: 373
Study: 16416643

Group type: EXPERIMENTAL
Intervention: Restylane Perlane
Number of subjects: 150

Group type: COMPARATOR
Intervention: Hylaform
Number of subjects: 150
Study: 12601486

Group type: EXPERIMENTAL
Intervention: Tc‐99m methoxyisobutylisonitrile (MIBI) imaging, 740 MBq dosage, imaging obtained 20 min after injection
Number of subjects: 15
Study: 10509569

Group type: EXPERIMENTAL
Intervention: Triple therapy and ZDV/ddl combination
Number of subjects: 1313

Group type: COMPARATOR
Intervention: Alternating ZDV/ddl and ZDV/ddC regimens
Number of subjects: 1313

Group type: EXPERIMENTAL
Intervention: QNPZ-4 scores
Number of subjects: 1313
Study: 8984939

Group type: EXPERIMENTAL
Intervention: 240 U kg‐1 r‐hu‐Epo subcutaneously, initially three doses weekly
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 1818427

Group type: EXPERIMENTAL
Intervention: Nizoral cream
Number of subjects: 72

Group type: COMPARATOR
Intervention: Clotrimazole ointment
Number of subjects: 72
Study: 7039643

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 47
Study: 31918683

Group type: EXPERIMENTAL
Intervention: Uncut Roux‐Y
Number of subjects: 236

Group type: COMPARATOR
Intervention: Roux‐Y
Number of subjects: 236
Study: 31159765

Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg/day (3 weeks followed by 1 week rest)
Number of subjects: 47
Study: 29176762

Group type: EXPERIMENTAL
Intervention: Prenatal lifestyle intervention (twice weekly group-exercises and dietary counseling)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Standard prenatal care (control)
Number of subjects: 606
Study: 25677721

Group type: EXPERIMENTAL
Intervention: Individualized social activities intervention (ISAI)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Treatment-as-usual (Control)
Number of subjects: 52
Study: 24380759

Group type: EXPERIMENTAL
Intervention: Left FLE
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Right FLE
Number of subjects: 43

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 43
Study: 23051883

Group type: EXPERIMENTAL
Intervention: Ultraport zero stopcock with hub disinfection before injection
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Ultraport zero stopcock without hub disinfection before injection
Number of subjects: 468

Group type: COMPARATOR
Intervention: Conventional open‐lumen stopcock
Number of subjects: 468
Study: 19716543

Group type: EXPERIMENTAL
Intervention: 17-alpha hydroxyprogesterone caproate
Number of subjects: 1094

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1094
Study: 18069770

Group type: EXPERIMENTAL
Intervention: subcutaneous rhGH (0.15 IU/kg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 48
Study: 15262836

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 748

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 748
Study: 11764514

Group type: EXPERIMENTAL
Intervention: Preexposure group (experimental) - subjects presented with the same set of stimuli in either the right or left hemifield, with nonattended symbols in the opposite hemifield.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group - subjects presented with a pair of geometric figures in either the right or left visual hemifield.
Number of subjects: 0
Study: 11264639

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 97

Group type: COMPARATOR
Intervention: Dual therapy (previous study)
Number of subjects: 97
Study: 9314699

Group type: EXPERIMENTAL
Intervention: Group psychotherapy with a focus on group cohesion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group psychotherapy with a focus on group therapeutic alliance
Number of subjects: 0
Study: 8350884

Group type: EXPERIMENTAL
Intervention: Intravaginal estriol (n = 50)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo (n = 43)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Intravaginal estriol
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 3785963

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30964416

Group type: EXPERIMENTAL
Intervention: H. halys (4 adults) with Fusarium (F. verticillioides inoculum)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: H. halys (4 adults) without Fusarium (no inoculum)
Number of subjects: 12

Group type: COMPARATOR
Intervention: H. halys (0 adults) with Fusarium (F. verticillioides inoculum)
Number of subjects: 12

Group type: COMPARATOR
Intervention: H. halys (0 adults) without Fusarium (no inoculum)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Interaction of H. halys and Fusarium treatments
Number of subjects: 12
Study: 29034751

Group type: EXPERIMENTAL
Intervention: Less than two hour invasive strategy (LT2)
Number of subjects: 1075

Group type: COMPARATOR
Intervention: Greater than two hour invasive strategy (GT2)
Number of subjects: 1075
Study: 27266776

Group type: EXPERIMENTAL
Intervention: Technology-based exercise for 6 months
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study: 24636382

Group type: EXPERIMENTAL
Intervention: Group-specific model including FACT-P subscale scores and baseline variables
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Two-part model including FACT-P subdomain scores and baseline variables
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Generalized estimating equation model including FACT-P subdomain scores and baseline variables
Number of subjects: 236
Study: 22894890

Group type: EXPERIMENTAL
Intervention: Chamomile extract (220 mg capsules standardized to 1.2% apigenin)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo (lactose monohydrate NF)
Number of subjects: 57
Study: 20650437

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 1004

Group type: COMPARATOR
Intervention: Fluoroscopic guidance
Number of subjects: 1004
Study: 18760137

Group type: EXPERIMENTAL
Intervention: Early revascularization intervention
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Antidiabetes regimens targeting insulin sensitivity
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Antidiabetes regimens targeting insulin provision
Number of subjects: 2368
Study: 16137351

Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilation (IPV)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard treatment (Control group)
Number of subjects: 33
Study: 12766934

Group type: EXPERIMENTAL
Intervention: 25 mg of oral dextro-amphetamine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 25
Study: 10634023

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) injection at the hip adductors and/or gastrocnemius
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) injection
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no BTA treatment)
Number of subjects: 38
Study: 8550117

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Diazepam and Alcohol (combination)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Diazepam and Propranolol (combination)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Alcohol and Propranolol (combination)
Number of subjects: 10
Study: 1683422

Group type: EXPERIMENTAL
Intervention: Injection of Escherichia coli endotoxin
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline injection (control group)
Number of subjects: 9
Study: 30817567

Group type: EXPERIMENTAL
Intervention: Corneal graft (3 layers of allogeneic cornea slices)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Scleral graft (sclera as allograft)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Both groups (corneal and scleral)
Number of subjects: 255